Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A1 | P46059 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | SLC1A1 | P43005 | 6/20 | 0.56 |
| ▸ | SLC1A3 | P43003 | 5/20 | 0.55 |
| ▸ | ALPI | P09923 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | XIAP | P98170 | 1/20 | 0.55 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.55 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5898461 | 1.00 | SLC15A1 (0.65) | SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A1 | |
| SCHEMBL730848 | 1.00 | SLC15A1 (0.65) | SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A1 | |
| Hydrochloric Acid SCHEMBL14482670 | 0.98 | SLC15A1 (0.63) | SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A1 | |
| Hydrochloric Acid SCHEMBL14482674 | 0.98 | SLC15A1 (0.63) | SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A1 | |
| Phenylalanine SCHEMBL744817 | 0.94 | SLC15A1 (0.71) | SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A1 | |
| Aspartic Acid SCHEMBL28852564 | 0.91 | SLC15A1 (0.56) | SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A1 | |
| SCHEMBL589203 | 0.90 | SLC15A1 (0.61) | SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A1 | |
| SCHEMBL1264374 | 0.90 | SLC15A1 (0.61) | SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A1 | |
| SCHEMBL589202 | 0.90 | SLC15A1 (0.61) | SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A1 | |
| SCHEMBL32681189 | 0.90 | SLC15A1 (0.61) | SLC15A1ALDH1A1MAPK1L3MBTL1SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115960154-A | 20-hydroxyprogesterone precursor compound and preparation method and application thereof | 新疆医科大学 | 2023-04-14 | — | — | CN | claimed |
| CN-112010935-B | Acetyl RGD modified hexacyclic piperazinedione, preparation, anti-tumor activity and application thereof | 首都医科大学 | 2022-08-05 | — | — | CN | claimed |
| CN-112010934-B | Acetyl RGD modified hexacyclic piperazinedione, preparation, transfer-resistant activity and application thereof | 首都医科大学 | 2022-08-02 | — | — | CN | claimed |
| CN-112010938-B | Acetyl RGD modified hexacyclic piperazinedione, preparation, anti-inflammatory activity and application thereof | 首都医科大学 | 2022-08-02 | — | — | CN | claimed |
| CN-112029091-B | PH/reduction dual-responsiveness block copolymer PEG-b-PASp-g-CPA | 中国药科大学 | 2022-06-10 | — | — | CN | claimed |
| CN-112472672-B | Polypeptide-polysaccharide graft copolymer based platinum nano prodrug and preparation method and application thereof | 西安交通大学 | 2022-01-25 | — | — | CN | claimed |
| CN-109535225-A | A kind of compound and its synthetic method and application | 暨南大学 | 2019-03-29 | — | — | CN | claimed |
| EP-1976873-A2 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS | Brystol-Myers Squibb Company (US) | 2008-10-08 | — | — | EP | claimed |
| US-20070238669-A1 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES RELATED CONDITIONS | BRISTOL-MYERS SQUIBB COMPANY | 2007-10-11 | — | — | US | claimed |
| WO-2007082264-A2 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-07-19 | — | — | WO | claimed |
| JP-3118354-A | — | — | None | — | — | JP | disclosed |
| CN-120965997-A | Preparation method of amphiphilic polyamino acid drug carrier | 宁德师范学院 | 2025-11-18 | — | — | CN | disclosed |
| WO-2025064683-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2025-03-27 | — | — | WO | disclosed |
| US-20250091989-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2025-03-20 | — | — | US | disclosed |
| US-20250025438-A1 | Derivative of aspartic acid and use thereof in treatment of metabolic diseases such as hepatic fibrosis and non-alcoholic hepatitis | SHENZHEN JINGTAI TECHNOLOGY CO., LTD. (CN) | 2025-01-23 | — | — | US | disclosed |
| EP-0205031-A1 | Process for the preparation of aspartic acid 4-benzyl ester | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-12-17 | — | — | EP | disclosed |
| CN-86103943-A | The preparation method of aspartic acid 4-benzyl ester | — | 1986-12-10 | — | — | CN | disclosed |
| CN-86103943-A | The preparation method of aspartic acid 4-benzyl ester | — | 1986-12-10 | — | — | CN | disclosed |
| CN-86103943-A | The preparation method of aspartic acid 4-benzyl ester | — | 1986-12-10 | — | — | CN | disclosed |
| US-3934027-A | 18β-Glycyrrhetinic acid amides useful as antiulcer agents | PFIZER INC. (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238669-A1 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES RELATED CONDITIONS | GLP1R, GIPR, IAPP | SLC15A1 1493/4885ALDH1A1 4570/4885MAPK1 2059/4885 |
| US-20250091989-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | MYC, KRAS, NRAS | SLC15A1 3793/4885ALDH1A1 2774/4885MAPK1 269/4885 |
| US-20250025438-A1 | Derivative of aspartic acid and use thereof in treatment of metabolic diseases such as hepatic fibrosis and non-alcoholic hepatitis | GOT1, GOT2, GLS2 | SLC15A1 207/4885ALDH1A1 38/4885MAPK1 1578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.